Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net revenues
Gross Profit
Operating expenses:        
Marketing expenses 52 114 236 460
Stock based compensation 50,000 37,500 150,000 112,500
Research and development 29,681 206,161 46,004 679,183
General and administrative 306,796 564,683 1,205,861 1,249,089
Total operating expenses 386,529 808,458 1,402,101 2,041,232
Loss from operations (386,529) (808,458) (1,402,101) (2,041,232)
Other expense:        
Other income (5,797)
Modification of warrants 24,770 17,505 24,770
Inducement of preferred shares 845,901
Interest expense 2,024 850 3,345 2,931
Interest expense - debt discount 70,211 263,719 140,090 423,663
Interest expense - original issuance costs 119,739 99,126 295,109 324,798
Total other expense 191,974 388,465 1,296,153 776,162
Loss before income taxes (578,503) (1,196,923) (2,698,254) (2,817,394)
Income taxes
Net loss $ (578,503) $ (1,196,923) $ (2,698,254) $ (2,817,394)
Net loss per share, basic $ (0.36) $ (0.94) $ (1.68) $ (2.26)
Net loss per share, diluted $ (0.36) $ (0.94) $ (1.68) $ (2.26)
Weighted average number of shares outstanding, Basic 1,605,377 1,268,795 1,605,377 1,245,885
Weighted average number of shares outstanding, Diluted 1,605,377 1,268,795 1,605,377 1,245,885